June 01, 2022
It is important to select good candidates for presbyopia-correcting IOL implantation and frankly discuss postoperative adjustment issues for a successful outcome.
May 31, 2022
Each new generation of cyclophotocoagulation options results in more accurate visualisation of the ciliary processes, greater ease of use and fewer complications.
May 30, 2022
Eye rubbing is an essential factor in the development of keratoconus. “No rub, no cone” is the rule: a genetic predisposition for the disease will come to nothing without excessive eye rubbing.
May 28, 2022
In a paper, investigators identified strategies used by patients to reduce the cost of therapy and its impact on adherence to treatment. Patients may be reluctant to disclose challenges regarding adherence to dry eye disease therapy, as well as fears of worsening quality of life.
May 26, 2022
Physicians offer pearls for improving visualisation in eyes using retroillumination techniques.
May 24, 2022
Practice makes perfect when adopting this method for intrascleral IOL fixation.
May 18, 2022
An investigator at Anglia Ruskin University is leading work on an anti-cataract drug, which has had positive results in lab tests.
May 18, 2022
BRIM Biotechnology Inc. has entered into a new strategic partnership with Ora Inc. for the late-stage clinical development of lead drug candidate BRM421 for dry eye syndrome (DES).
May 17, 2022
Polarisation-sensitive optical coherence tomography has facilitated early diagnosis of disease before it becomes apparent on topography.
May 16, 2022
Promising gene therapies in development are pinpointing steps in the pathogenic cascades involved in ocular diseases, such as VEGF for wet AMD and CFI for dry AMD.